What customs actually does with a peptide order

The short answer: in the US, Canada, the UK and Australia, an unapproved peptide mailed to you for your own use doesn't fit any of the normal personal-import exceptions. If it gets stopped, the usual outcome is that it's refused and destroyed, and the money is gone.

How likely a parcel is to be stopped is a different question, and nobody publishes that number. What the regulators do publish is the rules and what they do with what they catch. That's what this post covers, country by country, with a link to each regulator's own page.

Status as of October 21, 2026. This explains published import rules. It isn't legal advice, and it isn't advice on ordering or shipping anything.

Some do, and the number being stopped is clearly not small. No regulator publishes a seizure rate for peptide parcels, so anyone quoting odds is guessing.

What's on the record:

Here are the four countries side by side, then each one in detail.

Not legally, as a rule. FDA's personal importation page says: "In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use," and "If a drug is approved for use in another country but is an unapproved new drug in the U.S. it is illegal to import" (FDA, current as of Aug 18, 2025). BPC-157, TB-500, retatrutide and the rest of the usual list aren't FDA-approved drugs.

Then there's the part people quote on Reddit: FDA's personal importation policy. It's enforcement discretion, not a right. For a prescription product, FDA lists conditions that include all of these (FDA):

My read: a peptide sold on a US-facing website to US customers fails the "no known commercialization or promotion" test on day one, before you get to the doctor or the serious-condition parts. FDA hasn't published anything peptide-specific on this that I found, so that's my reading of its own criteria, not an FDA statement.

FDA also lists when it would refuse a personal import, including a product on an import alert, a shipment that "appears to be intended for commercial distribution," and a product that "appears to present a serious risk to health" (FDA).

FDA says you get a notice and a chance to respond. If the parcel is refused, it can be destroyed. CBP intercepts the package; FDA decides what happens to it.

Per FDA's own page on its destruction authority (FDA, current as of Mar 16, 2026):

On the question everyone actually wants answered: none of the FDA pages I read describe criminal charges for a person whose single personal-use parcel was refused. They describe refusal and destruction. That's not a promise about what can happen, and quantities that look commercial are treated differently.

Generally no. Health Canada's April 2026 advisory says "In Canada, peptides are generally regulated as prescription drugs," that "Unauthorized drug products are illegal in Canada," and that a "For Research Use Only" label "does not make these products legal or exempt from regulatory requirements" (Health Canada, Apr 9, 2026). It names BPC-157, CJC-1295, DSIP, Epitalon, GHK-Cu, HCG, Ipamorelin, KPV, Melanotan I and II, MOTS-C, NAD+, SS-31, TB-500 and retatrutide.

Health Canada's personal-use import guidance is blunt: "Generally, residents of Canada are not allowed to bring prescription drugs into Canada," and "This includes whether you carry them across the border or have them delivered by mail or courier" (Health Canada GUI-0116). The exceptions are narrow, like recent immigrants continuing a treatment, and the personal-use quantity is capped at "no more than a 90-day supply or a single course of treatment, whichever is less."

What happens to a stopped parcel: the same guidance says CBSA officers "may detain any health product they suspect does not comply," and products found non-compliant "will be refused entry or seized." It also says Health Canada can order unlawful imports removed from Canada or destroyed.

The MHRA hasn't published a page that answers this for peptides, at least not one I could find. What it has said is specific to retatrutide: "It has not been authorised for use in the UK, meaning anyone selling this product is doing so illegally. These products haven't been tested for safety, quality or effectiveness and there's no guarantee that they even contain retatrutide" (MHRA, Jul 24, 2026).

Most UK enforcement news is about suppliers, not buyers. The MHRA's criminal enforcement unit seized around 12,000 doses of unlicensed weight loss medicines, including retatrutide, tirzepatide and "peptide products," at a site near Northampton in May 2026 (MHRA, May 29, 2026), and over 12,000 fake retatrutide and tirzepatide pens in Birmingham on October 14 (MHRA, Oct 15, 2026).

At the border, Border Force works with the MHRA on seizures of illicit medicines, as in the March 2026 operation above. I didn't find a UK page describing what notice, if any, an individual gets when a single parcel is taken. So I'm not going to guess.

Only under the Personal Importation Scheme's conditions, and the TGA has said plainly that most peptide parcels it sees don't meet them.

The scheme lets individuals import unapproved therapeutic goods for themselves or immediate family, provided (TGA, updated Sep 8, 2026):

The TGA's May 2026 warning adds the peptide-specific part: "Importing unapproved peptide products under the Personal Importation Scheme is permitted only if the goods are clearly and accurately labelled to identify the therapeutic good." It describes intercepted products as unmarked vials, code-only labels, or missing the name and concentration of the active ingredient, and says "these vials will not be released" (TGA, May 7, 2026).

They're destroyed, and you lose the money. The TGA says that when peptide products don't meet import requirements, "we will notify the ABF to seize and destroy these products when they are intercepted at the border," and its head warned buyers "could also incur financial loss if the product is intercepted at the border and cannot be lawfully released" (TGA, May 7, 2026).

The scheme page goes further than any of the other three countries on consequences: "your products may be seized and destroyed. You may also face significant fines, or civil or criminal proceedings" (TGA).

No. The two regulators that address the label directly both say so. Health Canada says the label "does not make these products legal." FDA has warned companies selling GLP-1 products "falsely labeled 'for research purposes' or 'not for human consumption'" (FDA). I've covered why in what "research use only" actually means, and FDA spelled it out in its September letters to five vendors and October letters about vendor websites.

If you're in the US and want the version of this that involves a prescription, that's a different route with different rules: see can you legally get retatrutide and the peptide compounding status tracker.

If you've had a parcel stopped, reply and tell me which country and what paperwork, if any, you got. I'd like to know how closely the letters match what the regulators say they send.